Model Acts Program
The purpose of the Model Acts Program includes: A) advising states on establishing laws and policies to address illicit drug use issues and (B) revising such model state drug laws and draft supplementary model state laws to take into consideration changes in illicit drug use issues in the state involved.
General information about this opportunity
Last Known Status
Active
Program Number
95.006
Federal Agency/Office
Executive Office of The President
Type(s) of Assistance Offered
B - Project Grants
Program Accomplishments
Not applicable.
Authorization
Reauthorization of the Office of National Drug Control Policy (ONDCP), Public Law 115-271
Who is eligible to apply/benefit from this assistance?
Applicant Eligibility
Applicants must have expert knowledge and extensive experience in conducting research and analysis, providing technical assistance, and drafting model state drug laws, policies and programs.
Beneficiary Eligibility
Not applicable.
Credentials/Documentation
Applicants must have expert knowledge and extensive experience in conducting research and analysis, providing technical assistance, and drafting model state drug laws, policies and programs.
What is the process for applying and being award this assistance?
Pre-Application Procedure
Preapplication coordination is not applicable.
Application Procedure
This program is excluded from coverage under 2 CFR 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards.
Award Procedure
Upon approval by ONDCP, a grant letter and conditions are sent to the grantee.
Deadlines
Contact the headquarters or regional location, as appropriate for application deadlines
Approval/Disapproval Decision Time
From 30 to 60 days.
Appeals
Not applicable.
Renewals
Not applicable.
How are proposals selected?
Applications will not be considered that fail to demonstrate the organization's expertise and extensive experience in drafting model state drug laws, conducting research and analysis, and providing technical assistance on model state drug laws. Application must include: statement of the problem, program design and implementation, capabilities and competencies, budget worksheet and narrative, and performance measures.
How may assistance be used?
ONDCP is seeking a provider to:
- Conduct research and analysis on state and local drug laws, policies and programs;
- Draft comprehensive model state drug legislation, revise current model laws and draft supplementary model state laws; and
- Provide technical assistance and maintain a repository and web-based resource center on model state drug laws, policies and programs.
What are the requirements after being awarded this opportunity?
Reporting
Performance Reports: Federal Program Report required quarterly and final report to be submitted within 90 days.
Auditing
Not applicable.
Records
Grantee must keep complete records on the disposition of funds, and records related to the grant must be retained for 3 years.
Other Assistance Considerations
Formula and Matching Requirements
Statutory formula is not applicable to this assistance listing.
Matching requirements are not applicable to this assistance listing.
MOE requirements are not applicable to this assistance listing.
Length and Time Phasing of Assistance
The grant will be available for 24 months, with extensions possible. Method of awarding/releasing assistance: lump sum. Method of awarding/releasing assistance: Lump.
Who do I contact about this opportunity?
Regional or Local Office
None/Not specified.
Headquarters Office
Lisa Newton
1800 G Street, NW
Washington, DC 20503 US
Lisa_E_Newton@ondcp.eop.gov
Phone: 202-395-6639
Website Address
https://www.whitehouse.gov/ONDCP
Financial Information
Account Identification
11-1460-0-1-802
Obligations
(Project Grants (Cooperative Agreements)) FY 22$0.00; FY 23 est $2,698,275.00; FY 24 est $0.00; FY 21$2,500,000.00; -
Range and Average of Financial Assistance
Range varies based upon appropriated amount
Regulations, Guidelines and Literature
Not applicable.
Examples of Funded Projects
Not applicable.